Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus-infected patients is associated with the possession of HLA B51

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 83-92

  Bogdanos, D P ^a   Lenzi, M ^b   Okamoto, M ^a   Rigopoulou, E I ^c,d   Muratori, P ^b   Ma, Y ^a   Muratori, L ^b   Tsantoulas, D ^c,e   Mieli Vergani, G ^a   Bianchi, F B ^b   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SISMANOGLIO HOSPITAL   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

^e ATHENS MEDICAL CENTER   (Greece)

Author keywords

Hepatitis C virus; HLA B51; Immunological cross reactivity

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIGEN; CELL PROTEIN; CYTOCHROME P450 2D6; CYTOCHROME P450 2D6[252-271]; EPITOPE; HLA B51 ANTIGEN; INFECTED CELL PROTEIN 4; LIVER KIDNEY MICROSOME ANTIBODY; LIVER KIDNEY MICROSOME AUTOANTIBODY TYPE 1; MICROSOME ANTIBODY; POLYPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTI LIVER KIDNEY MICROSOME ANTIBODY; ANTI-LIVER KIDNEY MICROSOME ANTIBODY; HEPATITIS C ANTIBODY; HLA B ANTIGEN; HLA BW51; HLA-BW51; PEPTIDE FRAGMENT;

ADULT; AGED; ALLOTYPE; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE HEPATITIS TYPE 2; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HLA TYPING; HUMAN; IMMUNOGENETICS; IMMUNOREACTIVITY; INHIBITION KINETICS; KIDNEY MICROSOME; LIVER MICROSOME; MALE; MOLECULAR MIMICRY; PRIORITY JOURNAL; SEROLOGY; VIRUS CROSS REACTION; VIRUS IMMUNITY; ANTIBODY COMBINING SITE; BLOOD; GENETICS; GENOTYPE; HEPATITIS C VIRUS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KIDNEY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS;

ADULT; AGED; AMINO ACID SEQUENCE; AUTOANTIBODIES; BINDING SITES, ANTIBODY; CROSS REACTIONS; CYTOCHROME P-450 CYP2D6; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; KIDNEY; MALE; MICROSOMES, LIVER; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 5444251837     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700112     Document Type: Article

References (58)

1. Rizzetto M., G. Swana and D. Doniach. 1973. Microsomal antibodies in active chronic hepatitis and other disorders. Clin. Exp. Immunol. 15:331.
2. Homberg J.C., N. Abuaf, O. Bernard, et al. 1987. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 7:1333.
3. Alvarez F., P.A. Berg, F.B. Bianchi, et al. 1999. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 31:929.
4. Lunel F., N. Abuaf, L. Frangeul, et al. 1992. Liver/ kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 16:630.
5. Abuaf N., F. Lunel, P. Giral, E. Borotto, S. Laperche, R. Poupon, P. Opolon, J.M. Huraux and J.C. Homberg. 1993. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol. 18:359.
6. Clifford B.D., D. Donahue, L. Smith, E. Cable, B. Luttig, M. Manns and H.L. Bonkovsky. 1995. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613.
7. Bortolotti F., P. Vajro, F. Balli, R. Giacchino, C. Crivellaro, C. Barbera, M. Cataleta, L. Muratori, P. Pontisso, G. Nebbia, L. Zancan, A. Bertolini, A. Alberti and F. Bianchi. 1996. Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol. 25:614.
8. Cassani F., M. Cataleta, P. Valentini, P. Muratori, F. Giostra, R. Francesconi, L. Muratori, M. Lenzi, G. Bianchi, D. Zauli and F.B. Bianchi. 1997. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology. 26:561.
9. Nishioka M., S.A. Morshed, K. Kono, T. Himoto, S. Parveen, K. Arima, Watanabe S. and M.P. Manns. 1997. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol. 26:992.
10. Lenzi M., S. Bellentani, G. Saccoccio, P. Muratori, F. Masutti, L. Muratori, F. Cassant, F.B. Bianchi and C. Tiribelli. 1999. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45:435.
11. Giostra F., A. Manzin, M. Lenzi, et al. 1996. Low hepatitis C viremia levels in patients with anti-liver/ kidney microsomal antibody type 1 positive chronic hepatitis. J. Hepatol. 25:433.
12. Muratori L., M. Lenzi, M. Cataleta, F. Giostra, F. Cassani, G. Ballardini, D. Zauli and F.B. Bianchi. 1994. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol. 1994. 21:199.
13. Todros L., G. Saracco, M. Durazzo, M.L. Abate, G. Touscoz, L. Scaglione, G. Verme and M. Rizzetto. 1995. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology. 22:1374.
14. Alvarez F., O. Bernard, J.C. Homberg and G. Kreibich. 1985. Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J. Exp. Med. 161:1231.
15. Gueguen M., M. Meunier-Rotival, O. Bernard and F. Alvarez. Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J. Exp. Med. 168:801.
16. Manns M.P., E.F. Johnson, K.J. Griffin, E.M. Tan and K.F. Sullivan. 1989. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450dbl. J. Clin. Invest. 83:1066.
17. Muratori L., M. Parola, A. Ripalti, G. Robino, P. Muratori, G. Bellomo, R. Carini, M. Lenzi, M.P. Landini, E. Albano and F.B. Bianchi. 2000. Liver/ kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut. 46:553.
18. Yamamoto A.M., D. Cresteil, O. Boniface, F.F. Clerc and F. Alvarez. 1993. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur. J. Immunol. 23:1105.
19. Manns M.P., K.J. Griffin, K.F. Sullivan and E.F. Johnson. 1991. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J. Clin. Invest. 88:1370.
20. Muratori L., M. Lenzi, Y. Ma, M. Cataleta, G. Mieli-Vergani, D. Vergani and F.B. Bianchi. 1995. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut. 1995, 37:406.
21. Dalekos G.N., H. Wedemeyer, P. Obermayer-Straub, A. Kayser, A. Barut, H. Frank and M.P. Manns. 1999. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment. J Hepatol. 1999, 30:366.
22. Kerkar N., K. Choudhuri, Y. Ma, A. Mahmoud, O.P. Bogdanos, L. Muratori, F. Bianchi, R. Williams, G. Mieli-Vergani and D. Vergani. 2003. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 170:1481.
23. Geysen H.M., S.J. Barteling and R.H. Meloen. 1985. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. USA. 82:178.
24. Novotny J. 1991. Protein antigenicity: a thermodynamic approach. Mol. Immunol. 28:201.
25. Craig L., P.C. Sanschagrin, A. Rozek, S. Lackie, L.A. Kuhn and J.K. Scott. 1998. The role of structure in antibody cross-reactivity between peptides and folded proteins. J Mol Biol. 281:183.
26. Wucherpfennig K.W., I. Catz, S. Hausmann, J.L. Strominger, L. Steinman and K.G. Warren. 1997. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100:1114.
27. Johnson P.J. and I.G. McFarlane Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993, 18:998.
28. Lenzi M., M. Frisoni, V. Mantovani, P. Ricci, L. Muratori, R. Francesconi, M. Cuccia, S. Ferri and F.B. Bianchi. 1998. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 91:2062.
29. Tatusova T.A. and T.L. Madden. 1999. BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS. Microbiol. Lett. 174:247.
30. Rammensee H., J. Bachmann, N.P. Emmerich, O.A. Bachor and S.Stevanovic 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 50:213.
31. van 't Hof W., F.J. van Milligen, P.C. Driedijk, van den M. Berg and R.C. Aalberse. 1993. How to demonstrate specificity of antibody binding to synthetic peptides? J Immunol Methods 1993, 161:273.
32. Gregorio G.V., K. Choudhuri, Y. Ma, A. Vegnente, G. Mieli-Vergani and D. Vergani. 1999. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J. Immunol. 162:1802.
33. Bogdanos D.P., H. Baum, U.C. Sharma, A. Grasso, Y. Ma, A.K. Burroughs and D. Vergani. 2002. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J. Hepatol. 36:14.
34. Oldstone M.B. 1998. Molecular mimicry and immune-mediated diseases. Faseb. J. 12:1255.
35. Oldstone M.B. 1989. Virus-induced autoimmunity: molecular mimicry as a route to autoimmune disease. J. Autoimmun. 2 Suppl:187.
36. Michitaka K., M. Durazzo, H.L. Tillmann, D. Walker, T. Philipp and M.P. Manns. 1994. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology. 106:1603.
37. Zibert A., W. Kraas, R.S. Ross, H. Meisel, S. Lechner, G. Jung and M. Roggendorf. 1999. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection. J. Hepatol. 30:177.
38. Ray R., A. Khanna, L.M. Lagging, K. Meyer, Q.L. Choo, R. Ralston, M. Houghton and P.R. Becherer. 1994. Peptide immunogen mimicry of putative El glycoprotein-specific epitopes in hepatitis C virus. J. Virol. 68:4420.
39. Pirisi M., P. Ferroni, C. Fabris, P. Toniutto, G. Soardo, D. Vitulli, V. Gasparini and E. Bartoli. 1995. Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease. Infection. 23:24.
40. Wang Y.F., B. Brotman, L. Andrus and A.M. Prince. 1996. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J. Infect. Dis. 173:808.
41. Sercarz E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729.
42. Novotny J., M. Handschumacher, M. Haber, R.E. Bruccoleri, W.B. Carlson, D.W. Fanning, J.A. Smith and G.D. Rose. 1986. Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc. Natl. Acad. Sci. USA. 83:226.
43. Steinman L. 1999. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy. J. Exp. Med. 189:1021.
44. Tuohy V.K., M. Yu, L. Yin, J.A. Kawczak and R.P. Kinkel. 1999. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189:1033.
45. Misaki Y., K. Yamamoto, K. Yanagi, H. Miura, H. Ichijo, T. Kato, T. Mato, S. Welling-Wester, K. Nishioka and K. Ito. 1993. B cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein. Eur. J. Immunol. 23:1064.
46. Boulware S.L. and P.C. Weber. 2000. Cross-reactivity of the anti-PML antibody PG-M3 with the herpes simplex virus type 1 immediate early protein ICP4. J Gen Virol, 81:1773.
47. Douvas A. and S. Sobelman. 1991. Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses. Proc. Natl. Acad. Sci. 88:6328.
48. Kuhn J.E., G. Dunkler, K. Munk and R.W. Braun 1987. Analysis of the IgM and IgG antibody response against herpes simplex virus type 1 (HSV-1) structural and nonstructural proteins. J. Med. Virol. 23:135.
49. Kahlon J., F.D. Lakeman, M. Ackermann and R.J. Whitley. 1986. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J. Clin. Microbiol. 23:725.
50. Oldstone M.B. 1989. Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease. Curr. Top. Microbiol. Immunol. 145:127.
51. Mizuki N., M. Ota, K. Yabuki, et al. 2000. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest. Ophthalmol. Vis. Sci. 41:3702.
52. Ohno S., M. Ohguchi, S. Hirose, H. Matsuda, A. Wakisaka and M. Aizawa. 1982. Close association of HLA-Bw51 with Behcet's disease. Arch. Ophthalmol. 100:1455.
53. Mizuki N., H. Inoko, H. Tanaka, J. Kera, K. Tsuiji and S. Ohno. 1992. Human leukocyte antigen serologic and DNA typing of Behcet's disease and its primary association with B51. Invest. Ophthalmol. Vis. Sci. 33:3332.
54. Van de Water J., M.E. Gershwin, P. Leung, A. Ansari and R.L. Coppel. 1988. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J. Exp. Med. 167:1791.
55. Kita H., Z.X. Lian, J. Van de Water, et al. 2002. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195:113.
56. Jurado A., B. Cardaba, P. Jara, et al. 1997. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J. Hepatol. 26:983.
57. + T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol. 16:247.
58. Welsh R.M. and L.K. Selin. 2002. No one is naïve: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417.